About US
Contact us
-
GAO Report Faults FDA’s Response to Heparin CrisisAgency’s use of outside experts violated ethics rules Although the U.S. Food and Drug Administration’s (FDA) response to the contamination of heparin sodium in 2008 helped protect the public health2011/2/23
-
Sheffield Bio-Science forms strategic alliance with Wockhardt to strengthen cell culture media portfolioSheffield Bio-Science, a Kerry Group Business, has formed a strategic global sales, marketing and development alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science will be the Exc2011/2/23
-
Certain uses of terbutaline could lead to maternal heart problems and death, FDA warnsThe U.S. Food and Drug Administration is warning that terbutaline administered by injection or through an infusion pump should not be used in pregnant women for prevention or prolonged (beyond 48-72 h2011/2/22
-
Good Manufacturing Practice for Pharmaceutical Products (2010 revised edition) issuedThe Good Manufacturing Practice for Pharmaceutical Products (2010 revised edition) (hereinafter referred to as the new version of GMP) was recently issued and will come into effect as of March 1, 20112011/2/22
-
Sanofi-Aventis to Complete Overdue Genzyme AcquisitionFrench pharmaceutical firm Sanofi-Aventis has reached an agreement to acquire US-based biotechnology firm Genzyme for $20.1bn. Sanofi-Aventis had initially made a formal offer for Genzyme in Augus2011/2/17
-
UK Takes U-Turn on Chinese Medicine BanThe UK Government will allow several unlicensed herbal and Chinese medicines to escape a proposed European ban, which was due to go ahead in April. The controversial move will see health food shops2011/2/17
-
Lilly's Mirror Portfolio Reaches MilestoneLilly's Mirror Portfolio, a concept created to access exterior innovation, has acquired two molecules through an independent venture capitalist firm participating in the programme. One molecule, d2011/2/17
-
Sanofi-aventis, Sunnybrook enter agreement to develop and commercialize vasculotideSanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Sunnybrook Health Sciences Centre (Toronto, Canada) announced that they have entered into a research agreement and licensing option for vasculotide, an2011/2/17
-
FDA Funding to RiseThe US Food and Drug Administration (FDA) budget is set to rise by $147m to $2.7bn under President Obama's 2012 budget proposal. The agency is also set to receive approximately $1.6bn in fees paid2011/2/16
-
Study shows lower success rate of FDA drug approval from 2003 to 2010Biotechnology Industry Organization (BIO) Industry Analysis and BioMedTracker (BMT) announced results of a study today that shows the overall success rate for drugs moving through clinical trials to F2011/2/16